Literature DB >> 19663090

Fifty cases of vertebrobasilar ischemic vertigo treated by acupuncture.

Qiong Huang1.   

Abstract

OBJECTIVE: To observe the therapeutic effects of filiform needle acupuncture combined with dermal needle tapping for vertebrobasilar ischemic vertigo.
METHODS: Based on the etiopathogenesis of TCM, the disease is caused by turbid phlegm clouding the heart orifice combined with wind, leading to insufficient nourishment of the brain due to deficiency of blood. Fenglong (ST 40) was punctured with filiform needle to resolve phlegm; Fengchi (GB 20) to dispel wind; Baihui (GV 20) to stop dizziness; and Lieque (LU 7) to widen the inner diameter of the vertebral arteries and increase peak systolic velocity and minute blood flow volume, so as to improve blood supply to the vertebral arteries. Dazhui (GV 14) was stimulated by tapping with a dermal needle to improve blood supply to the head.
RESULTS: Of 50 patients in this series, 39 cases (78%) were cured, 6 cases (12%) relieved, 4 cases (8%) improved, and 1 case (2%) failed, with a total effective rate of 98%.
CONCLUSION: Acupuncture combined with dermal needle tapping is an effective therapy for treating vertebrobasilar ischemic vertigo.

Entities:  

Mesh:

Year:  2009        PMID: 19663090     DOI: 10.1016/s0254-6272(09)60038-8

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  2 in total

Review 1.  The Efficacy of Acupuncture for the Treatment of Cervical Vertigo: A Systematic Review and Meta-Analysis.

Authors:  Zhuanzhuan Hou; Shibing Xu; Qinglin Li; Libing Cai; Weigang Wu; Huida Yu; Huade Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-09       Impact factor: 2.629

Review 2.  Acupuncture Points Stimulation for Meniere's Disease/Syndrome: A Promising Therapeutic Approach.

Authors:  Jiaojun He; Liyuan Jiang; Tianqiang Peng; Meixia Xia; Huade Chen
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-28       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.